These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 1713458
1. Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets. Nolte C, Eigenthaler M, Schanzenbächer P, Walter U. Biochem Pharmacol; 1991 Jul 05; 42(2):253-62. PubMed ID: 1713458 [Abstract] [Full Text] [Related]
3. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors. Nolte C, Eigenthaler M, Horstrup K, Hönig-Liedl P, Walter U. Biochem Pharmacol; 1994 Oct 18; 48(8):1569-75. PubMed ID: 7980622 [Abstract] [Full Text] [Related]
4. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Horstrup K, Jablonka B, Hönig-Liedl P, Just M, Kochsiek K, Walter U. Eur J Biochem; 1994 Oct 01; 225(1):21-7. PubMed ID: 7925440 [Abstract] [Full Text] [Related]
7. Endothelium-dependent phosphorylation of vasodilator-stimulated protein in platelets during coronary passage. Pohl U, Nolte C, Bunse A, Eigenthaler M, Walter U. Am J Physiol; 1994 Feb 01; 266(2 Pt 2):H606-12. PubMed ID: 8141362 [Abstract] [Full Text] [Related]
8. 'VASPFix' for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonists. Glenn JR, Dovlatova N, White AE, Dhillon K, Heptinstall S, Fox SC. Thromb Haemost; 2014 Mar 03; 111(3):539-48. PubMed ID: 24258486 [Abstract] [Full Text] [Related]
9. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells. Hiroi T, Maruyama K, Hattori K, Ohnuki T, Nagatomo T, Watanabe K, Yamamoto T, Hara Y. Jpn J Pharmacol; 1997 May 03; 74(1):37-43. PubMed ID: 9195295 [Abstract] [Full Text] [Related]
10. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases. Waldmann R, Nieberding M, Walter U. Eur J Biochem; 1987 Sep 15; 167(3):441-8. PubMed ID: 2820726 [Abstract] [Full Text] [Related]
11. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP. Fisch A, Michael-Hepp J, Meyer J, Darius H. Eur J Pharmacol; 1995 May 26; 289(3):455-61. PubMed ID: 7556414 [Abstract] [Full Text] [Related]
12. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Aktas B, Utz A, Hoenig-Liedl P, Walter U, Geiger J. Stroke; 2003 Mar 26; 34(3):764-9. PubMed ID: 12624305 [Abstract] [Full Text] [Related]
13. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities. Ashby B. Mol Pharmacol; 1989 Dec 26; 36(6):866-73. PubMed ID: 2481225 [Abstract] [Full Text] [Related]
14. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion. Darius H, Binz C, Veit K, Fisch A, Meyer J. J Am Coll Cardiol; 1995 Sep 26; 26(3):800-6. PubMed ID: 7543911 [Abstract] [Full Text] [Related]
15. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. Ashby B. Mol Pharmacol; 1990 Jul 26; 38(1):46-53. PubMed ID: 1695318 [Abstract] [Full Text] [Related]
16. Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets. Macphee CH, Reifsnyder DH, Moore TA, Lerea KM, Beavo JA. J Biol Chem; 1988 Jul 25; 263(21):10353-8. PubMed ID: 2839485 [Abstract] [Full Text] [Related]
17. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators. Grünberg B, Kruse HJ, Negrescu EV, Siess W. J Cardiovasc Pharmacol; 1995 Apr 25; 25(4):545-51. PubMed ID: 7596121 [Abstract] [Full Text] [Related]
18. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets. Ashby B. Prostaglandins; 1992 Mar 25; 43(3):255-61. PubMed ID: 1378640 [Abstract] [Full Text] [Related]
19. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors. Ashby B. Second Messengers Phosphoproteins; 1988 Mar 25; 12(1):45-57. PubMed ID: 2848122 [Abstract] [Full Text] [Related]